Captrust Financial Advisors Praxis Precision Medicines, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$1.75 - $11.34 $2,353 - $15,252	1,345 New	1,345 $3,000
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $541 - $1,075	-53 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$13.15 - $22.56 $696 - $1,195	53 New	53 $1,000
Q2 2021 Aug 16, 2021	SELL	$18.28 - $33.05 $255 - $462	-14 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.34 - $60.2 $410 - $842	14 New	14 $0

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.